Showing 201 - 220 results of 1,337 for search '"Fibrosis"', query time: 0.05s Refine Results
  1. 201
  2. 202

    Liver Fibrosis and Mechanisms of the Protective Action of Medicinal Plants Targeting Inflammation and the Immune Response by Florent Duval, Jorge E. Moreno-Cuevas, María Teresa González-Garza, Carmen Maldonado-Bernal, Delia Elva Cruz-Vega

    Published 2015-01-01
    “…Inflammation is a central feature of liver fibrosis as suggested by its role in the activation of hepatic stellate cells leading to extracellular matrix deposition. …”
    Get full text
    Article
  3. 203
  4. 204

    Lithotripsy of Pancreatic Stones in a Patient with Cystic Fibrosis: Successful Treatment of Abdominal Pain by AA Weiss, JM Greig, S Fache

    Published 1992-01-01
    “…This article reports the case of an 18-year-old native Indian woman with cystic fibrosis who was experiencing pain related to pancreatitis, complicated by pancreatic duct stricture and lithiasis. …”
    Get full text
    Article
  5. 205

    A scoping review of the unmet needs of patients diagnosed with idiopathic pulmonary fibrosis (IPF). by Carita Bramhill, Donna Langan, Helen Mulryan, Jessica Eustace-Cook, Anne-Marie Russell, Anne-Marie Brady

    Published 2024-01-01
    “…<h4>Aims</h4>Patients diagnosed with idiopathic pulmonary fibrosis (IPF) have a high symptom burden and numerous needs that remain largely unaddressed despite advances in available treatment options. …”
    Get full text
    Article
  6. 206

    Tenascin C-Guided Nanosystem for Precision Delivery of Obeticholic Acid in Liver Fibrosis Therapy by Yawen Wang, Lei Yang, Qing Xu, Taiyu Liu, Hongliang He, Lisha Liu, Lifang Yin

    Published 2024-12-01
    “…<b>Objective:</b> Liver fibrosis, a hallmark of chronic liver diseases, is characterized by excessive extracellular matrix (ECM) deposition and scar tissue formation. …”
    Get full text
    Article
  7. 207

    Markers of Inflammation and Fibrosis in the Orbital Fat/Connective Tissue of Patients with Graves’ Orbitopathy: Clinical Implications by Przemyslaw Pawlowski, Joanna Reszec, Anja Eckstein, Kristian Johnson, Andrzej Grzybowski, Lech Chyczewski, Janusz Mysliwiec

    Published 2014-01-01
    “…FGF-β and TGF-β expression may contribute to tissue remodeling, fibrosis, and perpetuation of inflammation in the orbital tissue of GO especially in severe GO.…”
    Get full text
    Article
  8. 208
  9. 209

    Pentraxin 3 Is a Predictor for Fibrosis and Arterial Stiffness in Patients with Nonalcoholic Fatty Liver Disease by Kadir Ozturk, Omer Kurt, Tolga Dogan, Alptug Ozen, Hakan Demirci, Fatih Yesildal, Murat Kantarcioglu, Turker Turker, Ahmet Kerem Guler, Yıldırım Karslioglu, Battal Altun, Ahmet Uygun, Sait Bagci

    Published 2016-01-01
    “…PTX3 levels in NAFLD patients with fibrosis were higher than both NAFLD patients without fibrosis and controls (P=0.032 and P=0.028, respectively), but there was no difference between controls and NAFLD patients without fibrosis in terms of PTX3 levels (P=0.903). …”
    Get full text
    Article
  10. 210

    Therapeutic Effect and Location of GFP-Labeled Placental Mesenchymal Stem Cells on Hepatic Fibrosis in Rats by Jiong Yu, Guangshu Hao, Dan Wang, Jingqi Liu, Xiaotian Dong, Yanni Sun, Qiaoling Pan, Yang Li, Xiaowei Shi, Lanjuan Li, Hongcui Cao

    Published 2017-01-01
    “…Background. Liver fibrosis is a chronic progressive liver disease, but no established effective treatment exists except for liver transplantation. …”
    Get full text
    Article
  11. 211
  12. 212
  13. 213

    Optimized digital workflow for pathologist-grade evaluation in bleomycin-induced pulmonary fibrosis mouse model by Toshiki Goto, Akira Sano, Shinichi Onishi, Natsuko Hada, Rui Kimata, Saori Matsuo, Sohei Oyama, Atsuhiko Kato, Hideaki Mizuno, Masaki Yamazaki

    Published 2025-01-01
    “…Abstract Idiopathic pulmonary fibrosis (IPF) is a progressive and ultimately fatal disorder of unknown etiology, characterized by interstitial fibrosis of the lungs. …”
    Get full text
    Article
  14. 214

    Effect of Dead Volume on the Efficiency and the Cost to Deliver Medications in Cystic Fibrosis with Four Disposable Nebulizers by Sharon L Ho, Allan L Coates

    Published 1999-01-01
    “…OBJECTIVES: To evaluate the factors that affect nebulizer efficiency and to compare the relative cost effectiveness of nebulized medications used in the treatment of cystic fibrosis (CF), delivered by four types of disposable jet nebulizers that are widely used in hospitals.…”
    Get full text
    Article
  15. 215

    Fibrocyte enrichment and myofibroblastic adaptation causes nucleus pulposus fibrosis and associates with disc degeneration severity by Yi Sun, Yan Peng, Zezhuo Su, Kyle, K. H. So, Qiuji Lu, Maojiang Lyu, Jianwei Zuo, Yongcan Huang, Zhiping Guan, Kenneth M. C. Cheung, Zhaomin Zheng, Xintao Zhang, Victor Y. L. Leung

    Published 2025-01-01
    “…Our findings reveal that myeloid-derived fibrocytes play a pivotal role in NP fibrosis and may therefore be a target for modifying disc degeneration and promoting its repair.…”
    Get full text
    Article
  16. 216

    A Preliminary Report on Combined Penoscrotal and Perineal Approach for Placement of Penile Prosthesis with Corporal Fibrosis by John P. Brusky, Viet Q. Tran, Jocelyn M. Rieder, Sherif R. Aboseif

    Published 2008-01-01
    “…This paper aims at describing the combined penoscrotal and perineal approach for placement of penile prosthesis in cases of severe corporal fibrosis and scarring. Materials and methods. Three patients with extensive corporal fibrosis underwent penile prosthesis placement via combined penoscrotal and perineal approach from 1997 to 2006. …”
    Get full text
    Article
  17. 217

    Identification of a Mutation in the Novel Compound Heterozygous CFTR in a Chinese Family with Cystic Fibrosis by Hongxia Shao, Jingna Hua, Qi Wu, Xiaoge Li, Ming Zhang, Herong Wang, Junping Wu, Long Xu, Yi Xie, Li Li, Huaiyong Chen

    Published 2020-01-01
    “…Cystic fibrosis (CF) is one of the most common autosomal recessive disorders among Caucasians of Northern European descent but is uncommon in the Chinese population. …”
    Get full text
    Article
  18. 218

    Risk Factors and Changes of Peripheral NK and T Cells in Pulmonary Interstitial Fibrosis of Patients with Rheumatoid Arthritis by Na-Lin Lai, Wen Jia, Xia Wang, Jing Luo, Guang-Ying Liu, Chong Gao, Xiao-Feng Li, Jian-Fang Xie

    Published 2019-01-01
    “…The absolute and relative changes of peripheral NK and T subsets are unclear in rheumatoid arthritis (RA) associated with pulmonary interstitial fibrosis (RA-ILD). To investigate the clinical risk factors, especially the changes of lymphocyte subsets, in RA-ILD in order to make early diagnosis and achieve prevention of the pulmonary interstitial lesions. …”
    Get full text
    Article
  19. 219

    The EGFR-ADAM17 Axis in Chronic Obstructive Pulmonary Disease and Cystic Fibrosis Lung Pathology by Marta Stolarczyk, Bob J. Scholte

    Published 2018-01-01
    “…Chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) share molecular mechanisms that cause the pathological symptoms they have in common. …”
    Get full text
    Article
  20. 220

    Evaluating Adult Cystic Fibrosis Care in BC: Disparities in Access to a Multidisciplinary Treatment Centre by James M. Roberts, Pearce G. Wilcox, Bradley S. Quon

    Published 2016-01-01
    “…Background. Cystic fibrosis (CF) care that is delivered through dedicated, multidisciplinary CF clinics is believed to be partly responsible for improvements in the length and quality of life of persons with CF. …”
    Get full text
    Article